Thousands of NHS patients in England will participate in revolutionary trials for personalised cancer vaccines. The programme, a world-first matchmaking scheme dubbed the Cancer Vaccine Launch Pad, aims to fast-track individuals into clinical trials for custom-built vaccines that combat specific tumours. Elliot Pfebve, a 55-year-old lecturer diagnosed with colorectal cancer, is the first NHS patient to receive the personalised treatment at University Hospitals Birmingham NHS Trust.